SONN•benzinga•
Sonnet BioTherapeutics Receives Notice Of Allowance For U.S. Patent Covering Composition Of Matter Of Specific Amino Acid Substitutions Of Its IL-18 Binding Protein Resistant Variant Protein
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga